• Clinical Trial Tech – What Investors Want And Studies Need

    Clinical Research News | The perspectives of clinical trial technology investors and trends for future investment were the topics of a pair of fast-paced panel discussions at last week’s Summit for Clinical Ops Professionals (SCOPE) in Orlando. What investors want appears to be well aligned with what sponsors and sites say they need—solutions running the gamut from better matching patients to trials and improving access to streamlining the way studies get designed and conducted.

    Feb 20, 2024
  • SCOPE Summit 2024 Award Winners

    Clinical Research News | SCOPE Summit 2024 once again shined a spotlight on the breakthroughs, discoveries, and achievements of hundreds of organizations in their efforts to improve clinical trials and help patients worldwide. Three awards were presented at the conference: the Participant Engagement Award, the Site Innovation Award, and the Best of Show Award.

    Feb 15, 2024
  • Pharmaceutical Targets Identified For Osteoarthritis

    Clinical Research News | Researchers from the University of Adelaide (Australia) and the Columbia University (New York) have “reimagined” osteoarthritis, providing a pharmaceutical target for the discovery of drugs to reverse and treat the ubiquitous degenerative joint disease. Osteoarthritis was originally believed to be a “wear and tear” condition, and some people still refer to it that way, which wrongly implies that its progression is a matter of time and inevitable.

    Feb 13, 2024
  • New Products, Company News On Display at SCOPE

    Clinical Research News | The days leading up to the Summit for Clinical Ops Professionals—SCOPE—are a busy time for the clinical trials and clinical research space. The event kicked off yesterday and so far we’ve gathered these company and product news.

    Feb 12, 2024
  • New Patient Scoring Method To Enable Precision Medicine For Chronic Diseases

    Clinical Research News | In a big advance for precision medicine, researchers in Australia have developed a genetic biomarker of people’s response to sodium reduction. It is often but not always the case that modifying sodium levels lowers blood pressure by reducing the fluid volume of blood in the cardiovascular system, and knowing in advance how patients will respond could help eliminate the “treatment odyssey” that many of them are experiencing.

    Feb 8, 2024